Gastrointestinal Health

A few years ago, celiac disease was the popular gastrointestinal disorder. In the last year or so, though, irritable bowel syndrome has seemingly taken over.

In your pharmacy practice, you are actively trying to perform more comprehensive medication reviews and stress to patients the value of services you offer.

There are fewer micronutrient deficiencies among gastric bypass patients than previously indicated.

In gastroesophageal reflux disease, the reflux of stomach contents results in disruptive symptoms or complications.

Despite how common gastroesophageal reflux disease is among patients, there are a few unfounded beliefs surrounding its symptoms, severity, and treatment.

Irritable bowel syndrome is a chronic, functional, gastrointestinal disorder characterized by symptoms of abdominal pain associated with altered bowel habits.

Dexilant SoluTab is a delayed-release orally disintegrating tablet that treats heartburn associated with GERD.

The FDA today approved a new formulation of Takeda Pharmaceuticals' dexlansoprazole.

If patients come to the pharmacy with ailments like heartburn, stomach pain, and difficulty swallowing, they may have acid reflux or gastroesophageal reflux disease.

Because calcium citrate is not dependent on acid or pH for absorption, it may be the preferred calcium supplement for PPI users.

The best way to reduce health care spending is to teach patients how to optimize their health and slow the aging process.

Overall survival rate nearly doubles in patients who used aspirin post-diagnosis.

Gastroprotective agents may be needed in postmenopausal women taking bisphosphonates.

Pharmacists are positioned to educate and monitor older patients who are discharged on these medications.

Since patients with Barrett's esophagus seem to progress to cancerous stages faster than others, health care professionals might perceive that controlling acid reflux would prevent the transition.

Gastroesophageal reflux disease and atrial fibrillation are 2 of the most significant health concerns in the United States, and researchers suspect a link between them.

Narcotics are not recommended for managing chronic pain in children with inflammatory bowel disease, due to gastrointestinal side effects and potential dependence. Nevertheless, researchers have uncovered that long-term narcotic use is more than twice as prevalent in pediatric IBD patients compared with the general population.

Implementing interdisciplinary care reduces anesthetic exposures and related costs for pediatric patients with complex respiratory and gastrointestinal disorders.

A recent study suggests that co-administering the muscle relaxant, baclofen, with the proton pump inhibitor (PPI), omeprazole, may be more effective than PPI monotherapy in reducing heartburn and regurgitation in patients with gastroesophageal reflux disease (GERD).

As a result of confusing sensations of breathlessness with asthma symptoms, overweight and obese children tend to report poorer asthma control and overuse rescue medications.

Patients with irritable bowel syndrome cannot block pain signals from the gut as easily as those without the gastrointestinal condition.

The My GI Health tool tracks symptoms of gastroesophageal reflux disease over time, helping clinicians save time and improve patient care.

GERD patients are not following recommendations to avoid acid-triggering foods, according to a recent study.

Recent study on healing rates of reflux esophagitis patients suggests that some refractory patients may heal with extended acid suppression treatment.

A recent study indicates that eating meals quickly does not increase reflux episodes in gastroesophageal reflux disease patients.

A recent study found that rates of anti-reflux procedures vary greatly among pediatric hospitals and that there are no standardized guidelines for referrals for such procedures.

Children exposed to PPIs for more than 6 weeks are found to have an increased risk of non-specific gastric inflammation.

The use of prediction models can help clinicians identify patients who are unlikely to benefit from invasive investigation for Barrett's esophagus.